{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20260325",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "85543",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/216340s009lbl.pdf",
              "date": "20260327",
              "type": "Label"
            },
            {
              "id": "85544",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/216340Orig1s009ltr.pdf",
              "date": "20260327",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20221212",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "72869",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216340Orig1s000Corrected_lbl.pdf",
              "date": "20221220",
              "type": "Label"
            },
            {
              "id": "72870",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/216340Orig1s000ltr.pdf",
              "date": "20221213",
              "type": "Letter"
            },
            {
              "id": "73141",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/216340Orig1s000TOC.html",
              "date": "20230111",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20240621",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "78862",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216340s005lbl.pdf",
              "date": "20240621",
              "type": "Label"
            },
            {
              "id": "79124",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/216340Orig1s005ltr.pdf",
              "date": "20240718",
              "type": "Letter"
            },
            {
              "id": "80194",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2024/216340Orig1s005.pdf",
              "date": "20241112",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA216340",
      "sponsor_name": "BRISTOL",
      "openfda": {
        "application_number": [
          "NDA216340"
        ],
        "brand_name": [
          "KRAZATI"
        ],
        "generic_name": [
          "ADAGRASIB"
        ],
        "manufacturer_name": [
          "Mirati Therapeutics, Inc"
        ],
        "product_ndc": [
          "80739-812"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ADAGRASIB"
        ],
        "rxcui": [
          "2625917",
          "2625923"
        ],
        "spl_id": [
          "65724d4c-78ab-4d85-83b5-73b9da5c2cc3"
        ],
        "spl_set_id": [
          "0b8bf078-34c2-4f45-9012-38a8ac082b01"
        ],
        "package_ndc": [
          "80739-812-12",
          "80739-812-18"
        ],
        "unii": [
          "8EOO6HQF8Y"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "KRAZATI",
          "active_ingredients": [
            {
              "name": "ADAGRASIB",
              "strength": "200MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}